biologic

Brineura

cerliponase alfa

Loss of exclusivity—loss of exclusivity
CompanyBiomarin Pharmaceutical →See this company's full patent-cliff portfolio

Drug detail

Brand nameBrineura
Active ingredientcerliponase alfa
Strength150MG/5ML (30MG/ML)
Dosage formInjection
RouteIntraventricular
ModalityBiologic
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.